The agency is flagging risks from unapproved GLP-1 products sold for weight loss, with retatrutide named among them. Only a headline is available so far.
Recap by typeshit. Full story at ΕΜΥ.
A short Facebook clip where a doctor urges people on GLP-1 drugs to check their blood pressure. Details beyond the title are thin.
14:03
An animated explainer from The Infographics Show on two sides of tirzepatide: who can actually get it, and the safety questions that come with it.
Men's Fitness looks at BPC-157 and stacked peptides, arguing that getting the dose right is only part of the picture. Only the headline is available so far.
Pescatore flags thiamine as a nutrient to watch for patients on Ozempic or tirzepatide. His claim, shared as a short PSA clip.
Novo has lowered what it charges for Wegovy in China. Details on the size of the cut are in the full report.
Shares fell about 41% in a month after a $500 million raise. Investors want details on the new SUNRISE oral trial, which follows phase 2 weight loss of up to 12.2% in 13 weeks.
Loading…